{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:27:23Z","timestamp":1784921243050,"version":"3.55.0"},"reference-count":75,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Diabetic neuropathy is a serious complication of chronic hyperglycemia in diabetes patients. This complication can involve both peripheral sensorimotor and autonomic nervous system. The precise nature of injury to the peripheral nerves mediated by chronic hyperglycemia is unknown; however, several mechanisms have been proposed including polyol pathway activation, enhanced glycation of proteins and lipids, increased oxidative stress, and cytokine release in the site of injury. MicroRNAs (miRNAs) are small non-coding RNAs that mediate RNA interference by post-transcriptionally modulating gene expression and protein synthesis. Therefore, they have been implicated in several developmental, physiological, and pathophysiological processes where they modulate the expression of different proteins. Recently, miRNAs gained an increasing attention also for their role as diagnostic test in many diseases due to their stability in serum and their easy detection. Furthermore, recent studies suggest that miRNAs may be involved in diabetic neuropathy although their role in the onset and the development of this complication is not fully understood. In this review, we discuss the most recent literature providing evidence for miRNAs role in diabetic neuropathy opening new pathways to improve both early diagnosis and treatment of this complication.<\/jats:p>","DOI":"10.3390\/ijms20184627","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:01:15Z","timestamp":1568804475000},"page":"4627","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Insights into the Role of MicroRNAs in the Onset and Development of Diabetic Neuropathy"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3989-7703","authenticated-orcid":false,"given":"Raffaele","family":"Simeoli","sequence":"first","affiliation":[{"name":"Infectivology and Clinical Trials Area, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Viale San Paolo 15, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-9754","authenticated-orcid":false,"given":"Alessandra","family":"Fierabracci","sequence":"additional","affiliation":[{"name":"Infectivology and Clinical Trials Area, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Viale San Paolo 15, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/isl.3.4.15728","article-title":"Insulitis in human type 1 diabetes: The quest for an elusive lesion","volume":"3","year":"2011","journal-title":"Islets"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1210\/jc.2012-1206","article-title":"Formation of a human beta-cell population within pancreatic islets is set early in life","volume":"97","author":"Gregg","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.2337\/db10-0676","article-title":"Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study","volume":"59","author":"Keenan","year":"2010","journal-title":"Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1185\/030079907X182068","article-title":"Progress in the treatment of type 2 diabetes: New pharmacologic approaches to improve glycemic control","volume":"23","author":"Cohen","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1002\/jcp.27603","article-title":"Insulin resistance: Review of the underlying molecular mechanisms","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","article-title":"Long-term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.diabres.2007.09.005","article-title":"Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications","volume":"79","author":"Bravi","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/S1520-765X(03)90041-1","article-title":"Managing heart disease and potential new pharmacological therapies","volume":"5","author":"He","year":"2003","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/IJNRD.S40172","article-title":"Diabetic nephropathy-complications and treatment","volume":"7","author":"Lim","year":"2014","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF01228130","article-title":"Prognosis of diabetics with diabetes onset before the age of thirtyone","volume":"14","author":"Deckert","year":"1978","journal-title":"Diabetologia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.37.4.405","article-title":"Epidemiology of persistent proteinuria in type II diabetes mellitus: Population-based study in Rochester, Minnesota","volume":"37","author":"Ballard","year":"1988","journal-title":"Diabetes"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1681\/ASN.2004110970","article-title":"Pathogenetic mechanisms of diabetic nephropathy","volume":"16","author":"Schena","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.2337\/diacare.27.2007.S84","article-title":"Retinopathy in diabetes","volume":"27","author":"Fong","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2337\/dc06-2222","article-title":"Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: The 50-year medalist study","volume":"30","author":"Keenan","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and Macrovascular Complications of Diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin. Diabetes"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Vinik, A., Casellini, C., Nevoret, M.L., Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., Dungan, K., Grossman, A., and Hershman, J.M. (2019, September 12). Endotext [Internet]. Available online: MDText.com.","DOI":"10.3389\/fnins.2018.00591"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJM199205073261905","article-title":"Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus: A clinical and pathological study","volume":"326","author":"Said","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"(1988). Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). Diabetes Care, 11, 725\u2013732.","DOI":"10.2337\/diacare.11.9.725"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/j.diabres.2007.01.054","article-title":"Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptoms","volume":"77","author":"Yagihashi","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-119-1-199307010-00006","article-title":"Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: A randomized, controlled trial","volume":"119","author":"Litzelman","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: A statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.clinthera.2018.04.001","article-title":"Diabetic peripheral neuropathy: Epidemiology, diagnosis, and pharmacotherapy","volume":"40","author":"Iqbal","year":"2018","journal-title":"Clin. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.pain.2011.01.042","article-title":"MicroRNAs as new players in the pain game","volume":"152","author":"Niederberger","year":"2011","journal-title":"Pain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1474-9726.2012.00824.x","article-title":"Genome-wide miRNA signatures of human longevity","volume":"11","author":"ElSharawy","year":"2012","journal-title":"Aging Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.3390\/molecules19056891","article-title":"Circulating miRNAs as biomarkers for neurodegenerative disorders","volume":"19","author":"Grasso","year":"2014","journal-title":"Molecules"},{"key":"ref_32","first-page":"19","article-title":"Biomarkers of multiple sclerosis: Current findings","volume":"7","author":"Harris","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","article-title":"Alterations of the microRNA network cause neurodegenerative disease","volume":"32","author":"Hebert","year":"2009","journal-title":"Trends Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1038\/srep10201","article-title":"Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"La Marca, V., and Fierabracci, A. (2017). Insights into the diagnostic potential of extracellular vesicles and their miRNA signature from liquid biopsy as early biomarkers of diabetic micro\/macrovascular complications. Int. J. Mol. Sci., 18.","DOI":"10.20944\/preprints201709.0027.v1"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/CS20130079","article-title":"microRNA in the development of diabetic complications","volume":"126","author":"McClelland","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nrn2037","article-title":"The neuronal microRNA system","volume":"7","author":"Kosik","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.4815-07.2008","article-title":"Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus","volume":"28","author":"Davis","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20070823","article-title":"Cerebellar neurodegeneration in the absence of microRNAs","volume":"204","author":"Schaefer","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12017-009-8065-2","article-title":"MicroRNA regulation of synaptic plasticity","volume":"11","author":"Smalheiser","year":"2009","journal-title":"Neuromol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.1523\/JNEUROSCI.3030-10.2010","article-title":"MicroRNA loss enhances learning and memory in mice","volume":"30","author":"Konopka","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1167\/iovs.10-6879","article-title":"MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats","volume":"52","author":"Kovacs","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_43","first-page":"4","article-title":"Inflammatory mediators in diabetic neuropathy","volume":"S5","author":"Wilson","year":"2011","journal-title":"J. Diabetes Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajpath.2011.04.021","article-title":"miR-21 and miR-214 are consistently modulated during renal injury in rodent models","volume":"179","author":"Denby","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.21675","article-title":"Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: A randomized, double-blinded trial","volume":"65","author":"Ropper","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db11-0082","article-title":"Diabetes complications: The microRNA perspective","volume":"60","author":"Kantharidis","year":"2011","journal-title":"Diabetes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.pain.2011.02.024","article-title":"Hypoxia-induced sensitization of transient receptor potential vanilloid 1 involves activation of hypoxia-inducible factor-1 alpha and PKC","volume":"152","author":"Ristoiu","year":"2011","journal-title":"Pain"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/DDDT.S157109","article-title":"Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation","volume":"12","author":"Feng","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.4049\/jimmunol.0900707","article-title":"MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2","volume":"183","author":"Hou","year":"2009","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2337\/db16-1182","article-title":"MicroRNA-146a mimics reduce the peripheral neuropathy in type 2 diabetic mice","volume":"66","author":"Liu","year":"2017","journal-title":"Diabetes"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1742-2094-10-133","article-title":"ADAMTS proteoglycanases in the physiological and pathological central nervous system","volume":"10","author":"Lemarchant","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuroscience.2013.11.057","article-title":"The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy","volume":"259","author":"Wang","year":"2014","journal-title":"Neuroscience"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13105-014-0378-4","article-title":"Deregulation of NF-small ka, CyrillicB-miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy","volume":"71","author":"Yousefzadeh","year":"2015","journal-title":"J. Physiol. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1567202614666170404115912","article-title":"MiR-106a Associated with diabetic peripheral neuropathy through the regulation of 12\/15-LOX-mediated oxidative\/nitrative stress","volume":"14","author":"Wu","year":"2017","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trsl.2016.06.005","article-title":"Prophylactic L-arginine and ibuprofen delay the development of tactile allodynia and suppress spinal miR-155 in a rat model of diabetic neuropathy","volume":"177","author":"Matboli","year":"2016","journal-title":"Transl. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s12035-016-9700-1","article-title":"miR-9 mediates CALHM1-activated ATP-P2X7R signal in painful diabetic neuropathy rats","volume":"54","author":"Liu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbrc.2014.12.004","article-title":"Altered microRNAs expression profiling in mice with diabetic neuropathic pain","volume":"456","author":"Gong","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Guo, G., Liu, Y., Ren, S., Kang, Y., Duscher, D., Machens, H.G., and Chen, Z. (2018). Comprehensive analysis of differentially expressed microRNAs and mRNAs in dorsal root ganglia from streptozotocin-induced diabetic rats. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202696"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2147\/JPR.S133755","article-title":"The role of miR-190a-5p contributes to diabetic neuropathic pain via targeting SLC17A6","volume":"10","author":"Yang","year":"2017","journal-title":"J. Pain Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuint.2016.05.008","article-title":"Changes in VGLUT1 and VGLUT2 expression in rat dorsal root ganglia and spinal cord following spared nerve injury","volume":"99","author":"Wang","year":"2016","journal-title":"Neurochem. Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/s41467-017-01841-5","article-title":"Exosomal cargo including microRNA regulates sensory neuron to macrophage communication after nerve trauma","volume":"8","author":"Simeoli","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3727\/096368913X675728","article-title":"Recent advances in mesenchymal stem cell immunomodulation: The role of microvesicles","volume":"24","author":"Fierabracci","year":"2015","journal-title":"Cell Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3727\/096368915X687543","article-title":"Immunoregulatory effects of mesenchymal stem cell-derived extracellular vesicles on T Lymphocytes","volume":"24","author":"Luciano","year":"2015","journal-title":"Cell Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1096\/fj.201800597R","article-title":"Exosomes derived from high-glucose-stimulated schwann cells promote development of diabetic peripheral neuropathy","volume":"32","author":"Jia","year":"2018","journal-title":"FASEB J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"16983","DOI":"10.1523\/JNEUROSCI.3352-10.2010","article-title":"Atypical protein kinase C regulates primary dendrite specification of cerebellar purkinje cells by localizing Golgi apparatus","volume":"30","author":"Tanabe","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1101\/gad.1975411","article-title":"miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis","volume":"25","author":"Kole","year":"2011","journal-title":"Genes Dev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12013-014-0029-y","article-title":"MiR-29b protects dorsal root ganglia neurons from diabetic rat","volume":"70","author":"Zhang","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/excr.1995.1005","article-title":"The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization","volume":"216","author":"Lynch","year":"1995","journal-title":"Exp. Cell Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/NEN.0000000000000219","article-title":"Evidence for epigenetic regulation of gene expression and function in chronic experimental diabetic Neuropathy","volume":"74","author":"Cheng","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00592-014-0582-2","article-title":"Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes","volume":"51","author":"Ciccacci","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdiacomp.2017.10.011","article-title":"Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes","volume":"32","author":"Ciccacci","year":"2018","journal-title":"J. Diabetes Complicat."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3892\/mmr.2017.6874","article-title":"miR-199a-3p is involved in the pathogenesis and progression of diabetic neuropathy through downregulation of SerpinE2","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e5443","DOI":"10.1097\/MD.0000000000005443","article-title":"Identification of genes and signaling pathways associated with diabetic neuropathy using a weighted correlation network analysis: A consort study","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/18\/4627\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:23Z","timestamp":1760188883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/18\/4627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":75,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["ijms20184627"],"URL":"https:\/\/doi.org\/10.3390\/ijms20184627","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]}}}